Customs Clearance for Medical Devices in Malaysia

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Customs clearance is where the registration and licensing work is tested against a physical consignment. The party that clears the goods is the importer, which must be an establishment holding an EL and whose import activity is authorised by the AR, or a customs broker or freight forwarder appointed by that importer. Enforcement at the border rests with the Royal Malaysian Customs Department, while the MDA exercises its role as the designated government agency at the licensing stage.

  • The importer must be licensed. Clearance requires an establishment holding an EL, with import activity covered by AR authorisation, or a broker acting for that importer.
  • Two authorities, two functions. The Royal Malaysian Customs Department enforces at the border; the MDA controls the licensing gate as the designated agency.
  • HS classification decides the paperwork. The import permit regime identifies medical devices by HS code, so the code determines whether a permit or verification slip is required at all.
  • Registration status is checked routinely. An unregistered device that arrives at the port faces detention, and the matter may engage section 5(1) of Act 737.
  • The document set is standard plus one addition. Commercial invoice, packing list, transport document, certificate of origin, EL evidence and the registration certificate; from 1 July 2027 the MDA import permit is added.
  • The transition period is for rehearsal. Current procedures apply until 1 July 2027, and the voluntary window from June 2026 is the opportunity to test classification and system access.

2. Legal basis

The clearance obligation sits at the intersection of two regimes. Under Act 737, the importer must be an establishment holding a licence, and its import activity must be covered by the authorisation chain running from the manufacturer through the AR. Under the Customs (Prohibition of Import) Order 2023, medical devices are subject to import permit control, with the MDA designated as the agency responsible for issuing permits and with HS codes used to identify which goods fall within scope. The Royal Malaysian Customs Department enforces the customs law at the point of entry.

The HS code is the pivot of the permit regime because the regime identifies devices by code rather than by description. Classification therefore determines whether an import permit or a verification slip is required for a particular consignment. A wrong classification has two possible consequences: goods that need a permit clear without one, which creates exposure discovered later, or goods that do not need a permit are held while the paperwork is completed. Both outcomes cost time, and the second is the more common in practice.

DocumentPurpose at clearance
Commercial invoiceValue and transaction evidence
Packing listConsignment composition
Bill of lading or air waybillTransport and consignee
Certificate of originOrigin declaration
Importer EL evidenceConfirms licensed establishment
Product registration certificateConfirms the device is registered
MDA import permitRequired from 1 July 2027

Duty and tax treatment follows the customs tariff rather than the device regulations, which is why the tariff classification matters for two separate reasons: permit scope and duty exposure. The two questions should be answered together, because a classification chosen to optimise one may create a problem under the other.

The interaction between registration and clearance is direct. Checking the registration status of a device at the border is a routine risk control action rather than an exceptional measure. A product without a registration certificate that arrives at the port faces detention, and the position may engage section 5(1) of Act 737, since that provision prohibits import of an unregistered device. The clearance question is therefore not merely administrative: an unregistered consignment is evidence of a substantive breach.

Until 1 July 2027, the current customs declaration process continues to apply. The voluntary submission window that opens in June 2026 allows importers to complete system familiarisation and code verification ahead of enforcement, and it is the only structured opportunity to test the workflow against a real consignment before the requirement becomes binding.

3. Expert insights

Clearance delays are rarely caused by missing documents in the abstract and almost always by a mismatch between documents. The invoice describes one thing, the packing list another, the registration certificate covers a variant that is not the one shipped, and the HS code on the declaration does not match the code on which the permit was sought. Each document is individually correct, and the consignment still stops, because the officer’s task is to reconcile them.

The registration certificate is the document most often misaligned. A certificate covers a device as registered, including its grouping and its variants; a shipment that includes a variant outside that grouping is a shipment of an unregistered device, even though the family name on the invoice matches. This is a classification problem in the regulatory sense rather than the tariff sense, and it is invisible unless someone compares the shipping documents against the certificate scope before the goods leave.

The practical discipline that prevents most of this is documentary continuity: the same evidence travels with the goods and is available at both the customs point and the receiving facility. Hospital acceptance procedures ask questions that resemble customs questions, and an organisation that has already assembled the evidence once answers both without reconstructing the file.

4. Practical recommendations

  • Confirm, before each shipment, that the consignee is an EL-holding establishment and that its import activity is covered by the AR authorisation, rather than assuming the standing arrangement continues to apply.
  • Reconcile the shipping documents against the registration certificate scope, including variants and grouping, so that the consignment matches what is registered rather than what is catalogued.
  • Have the AR or importer provide scanned copies of the registration certificate, the EL and, once applicable, the import permit to travel with the goods, so that the same evidence is available at customs and at hospital acceptance.
  • Agree HS classifications with the customs broker item by item and record them, so that subsequent consignments are declared consistently.
  • Use the period before 1 July 2027 to run a consignment through the voluntary verification route, treating it as a test of the full documentary chain rather than of a single form.
  • Track duty and permit consequences of a classification together, since a code that reduces duty exposure may widen or narrow permit scope.

5. Verification checklist

  • □ Confirm the scope of the Customs (Prohibition of Import) Order 2023 and the MDA HS code list.
  • □ Confirm the MDA import permit announcement of 1 December 2025 and the enforcement date of 1 July 2027.
  • □ Confirm the division of enforcement responsibility between the Royal Malaysian Customs Department and the MDA against the Chambers Global Practice Guide 2020, Malaysia chapter.
  • □ Confirm the current documentary requirements with the appointed customs broker before each first shipment of a new device.
  • □ Confirm that the registration certificate covers every variant in the consignment.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Malaysia. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the MDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail